Format

Send to

Choose Destination
J Cell Biol. 2012 Oct 29;199(3):417-21. doi: 10.1083/jcb.201207033.

Hypertrophic cardiomyopathy: translating cellular cross talk into therapeutics.

Author information

1
Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.

Abstract

Hypertrophic cardiomyopathy (HCM) is a common inherited heart disease with serious adverse outcomes, including heart failure, arrhythmias, and sudden cardiac death. The discovery that mutations in sarcomere protein genes cause HCM has enabled the development of mouse models that recapitulate clinical manifestations of disease. Studies in these models have provided unexpected insights into the biophysical and biochemical properties of mutated contractile proteins and may help to improve clinical diagnosis and management of patients with HCM.

PMID:
23109667
PMCID:
PMC3483129
DOI:
10.1083/jcb.201207033
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center